American Assn for the Study of Liver Diseases
Based in VA
AI Overview
With $1.4M in lobbying spend across 28 quarterly filings, American Assn for the Study of Liver Diseases is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $150K |
| 2021 | $100K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $150K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Health Issues
Medicare reimbursement rates
MACRA Implementation, Chronic Care Reform
Liver Disease Research & Funding
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Liver Disease Research & Funding
H.R.no bill #/S.3158 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Liver Disease Research & Funding
H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019.
Medicare reimbursement rates
MACRA Implementation Chronic Care Reform
Liver Disease Research & Funding
H.R. 6157 Department of Defense & Labor, Health & Human Services & Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019.
Liver Disease Research & Funding
HR 2740 Labor, HHS, Education, Defense, State, Foreign Operations and Energy and Water Development Appropriations Act, 2020
FDA guidance on Non-Alcoholic Steatohepatitis
Showing 8 of 19 unique descriptions from filings.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.